Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Biopreservation and Biobanking|October 7, 2011
Variation of Peripheral Blood Mononuclear Cell RNA Quality in Archived SamplesZisis Kozlakidis, Christine Mant, Fartun Abdinur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Cutting edge: a chemical genetic system for the analysis of kinases regulating T cell developmentAngela Denzel, Katherine J Hare, Chao Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2013
γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse modelJanet G M Markle, Steve Mortin-Toth, Andrea S L Wong, et al.
Science Translational Medicine|April 11, 2014
Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathwayPierre Vantourout, Carrie Willcox, Andrea Turner, et al.
International Journal of Cancer|July 28, 2011
Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammationMieke Van Hemelrijck, Ingmar Jungner, Göran Walldius, et al.
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 20, 2021
OMIP-079: Cell cycle of CD4<sup>+</sup> and CD8<sup>+</sup> naïve/memory T cell subsets, and of Treg cells from mouse spleenAmbra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Nature Medicine|September 23, 2014
Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infantsDeena Gibbons, Paul Fleming, Alex Virasami, et al.
Cancer Causes & Control : CCC|June 10, 2010
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyMieke Van Hemelrijck, Hans Garmo, Elisa Binda, et al.
Pageof 5